Why does my body odour smell like feces?
The faecal component of body odour is primarily caused by skatole (3-methylindole), a molecule produced when bacteria in your gut break down the amino acid tryptophan. Skatole is absorbed from the intestine into your bloodstream, processed by your liver, and can be excreted through sweat. This is biochemically distinct from the sour or onion-like body odour that originates from bacteria on your skin surface. Because skatole reaches the skin through the bloodstream, this odour can appear anywhere on the body, not only in the armpits.
If your body has a faecal odour that persists despite thorough hygiene, there is a biochemical explanation. The molecule most commonly responsible is skatole, also known as 3-methylindole. It is produced when certain bacteria in the large intestine break down the amino acid tryptophan, and it can enter the bloodstream, pass through the liver, and be excreted through sweat and other secretions.
This is a different biochemical pathway from the sour or onion-like armpit odour most people associate with body odour. Those smells originate from bacteria on the skin surface breaking down sweat precursors. Faecal body odour, in many cases, originates from inside the body. Understanding the distinction is the first step toward managing it.
This article explains what skatole is, how it is produced, how it reaches the skin, what conditions can increase its production, and what the scientific evidence says about addressing it. Every claim is backed by peer-reviewed research. Where the science is still emerging, that is stated explicitly.
1. The molecule behind the smell: skatole
Skatole (3-methylindole) is a nitrogen-containing heterocyclic compound formed during bacterial degradation of the amino acid L-tryptophan in the mammalian intestine.[1] Its name derives from the Greek skatos, meaning dung, and it has been recognised as a principal contributor to the characteristic odour of faeces since the nineteenth century.
Skatole has an exceptionally low odour detection threshold, with airborne concentrations in the low nanograms-per-litre range sufficient to produce a perceptible faecal note.[7] Unlike indole, a closely related molecule that smells floral at low concentrations and faecal only at higher concentrations, skatole has a faecal odour character at every detectable concentration. This distinction matters: even trace quantities of skatole reaching the skin surface can produce a perceptible faecal note.
Skatole is lipophilic, meaning it dissolves readily into fats, oils, and organic solvents rather than water.[7] On skin, this means skatole accumulates in the oily layers and is released gradually, which helps explain why the odour can persist even after washing. If you experience body odour that survives showering, read why you still smell after showering for the full explanation of that mechanism.
In plain terms What is skatole, and why does it smell so strongly?
Skatole is a chemical compound produced by bacteria in your gut. It is the main reason faeces have their characteristic smell. The human nose can detect it at extremely low concentrations, so even tiny amounts reaching your skin can produce a noticeable odour. Because skatole dissolves easily into the oily layer of your skin, it can linger even after you shower.
2. How your gut bacteria produce skatole
The production of skatole begins with tryptophan, one of the nine essential amino acids obtained from dietary protein. Approximately 95% of dietary tryptophan is metabolised through the hepatic kynurenine pathway.[4] The remaining fraction that reaches the colon unabsorbed becomes available to gut bacteria.
Two distinct microbial pathways convert this colonic tryptophan into odorous metabolites. The first is the indole pathway: more than 85 gram-positive and gram-negative bacterial species possess the enzyme tryptophanase, which converts L-tryptophan directly into indole, pyruvate, and ammonia.[2] Among the most widely studied indole producers in the human gut are Escherichia coli, Clostridium species, and several Bacteroides species.[2] The faecal concentration of indole in healthy adults has been measured in a wide range, from 0.30 to 6.64 millimoles.[2]
The second pathway produces skatole. The conversion was characterised using isotope-labelled substrates in Clostridium drakei and Clostridium scatologenes: tryptophan is first converted to indole-3-acetic acid (IAA) through an indolepyruvate intermediate, and IAA is then decarboxylated to form skatole.[3] Within the human gut, Clostridium and Bacteroides genera are the primary catalysts for this conversion, though they represent less than 0.01% of the total intestinal microbiota.[2] Other species identified as skatole producers include Clostridium sporogenes.[7]
The concentration of skatole in healthy human faeces is approximately 5 to 16 micrograms per gram.[2][7] In individuals with digestive disorders, faecal skatole can increase substantially, reaching 80 to 100 micrograms per gram.[2] When gut conditions favour proteolytic bacteria, skatole production increases.
In plain terms Where does skatole come from?
When you eat protein, some of it reaches your large intestine without being fully absorbed. Bacteria living there break down this protein, specifically an amino acid called tryptophan. Two groups of bacteria handle this differently: one group produces indole (which smells floral in small amounts), and another group produces skatole (which smells faecal at any concentration). The amount of skatole produced depends on which bacteria are dominant in your gut and how much protein reaches them.
3. How skatole reaches your skin
Once produced in the colon, skatole is absorbed into the bloodstream. As a lipophilic compound, it crosses the intestinal epithelium readily and is transported to the liver, where cytochrome P450 enzymes metabolise it before it can reach systemic circulation.
In human liver microsomes, multiple cytochrome P450 enzymes contribute to skatole metabolism, including CYP1A2, CYP2E1, and CYP3A4.[5] These enzymes oxidise skatole through several pathways, producing metabolites that are then cleared from the body. The combined efficiency of these hepatic clearance pathways determines how much skatole escapes the liver and enters systemic circulation.
Variation in cytochrome P450 enzyme activity between individuals affects how efficiently the liver clears skatole. A nonfunctional variant of CYP2F1 has been identified, and variation in other CYP isoforms may result in slower skatole clearance, leading to higher circulating levels from the same dietary and microbial inputs.[5]
Skatole that escapes hepatic clearance enters systemic circulation and can be excreted through urine, breath, and sweat. Because skatole is lipophilic, it accumulates in the oily layers of the skin and is released gradually. Because skatole arrives at the skin through the bloodstream rather than through localised bacterial activity, it can surface anywhere on the body where sebaceous glands and sweat glands are present. This is not an armpit problem. It is a whole-body problem. The chest, back, torso, groin, and limbs are all potential sites of skatole excretion.
An important note on scientific certainty: the gut production of skatole and its hepatic metabolism are well characterised in peer-reviewed literature. The specific quantification of skatole excretion through human sweat glands is an area of active research with limited direct measurement data. The pathway from gut to skin is established in principle and supported by pharmacokinetic modelling, but the precise contribution of sweat-mediated excretion versus other routes is still being characterised. This article presents what the evidence supports and identifies where the frontier lies.
In plain terms How does a molecule from my gut end up on my skin?
After bacteria in your gut produce skatole, it is absorbed into your bloodstream and carried to your liver. Your liver tries to break it down and send the fragments to your kidneys for removal. If the liver cannot fully clear it, whether due to genetics, liver stress, or sheer volume of skatole, the remainder circulates in your blood. Because skatole dissolves easily into oil, it accumulates in the oily layers of your skin and can be released gradually. This is why the odour can persist throughout the day and survive showering. And because the molecule arrives through the blood, not from bacteria on the skin, it can appear anywhere on the body, not just the armpits. The chest, back, and groin are equally affected.
4. Why some people are affected more than others
Three factors determine an individual's susceptibility to faecal body odour from the skatole pathway: how much skatole their gut produces, how efficiently their liver clears it, and what they eat.
Dietary protein and tryptophan load
Dietary tryptophan load directly modulates intestinal indole production. In laboratory models simulating the human gut microbiome, high-protein diets significantly increase microbial production of indole and related tryptophan catabolites compared to high-fibre diets.[8] Foods especially rich in tryptophan include turkey, chicken, cheese, eggs, soybeans, and chocolate. For a broader look at how diet influences body odour across multiple pathways, read foods that cause body odour. The more unabsorbed tryptophan that reaches the colon, the more substrate is available for skatole-producing bacteria.
Conversely, increasing dietary fibre intake, particularly prebiotic fibres such as inulin-type fructans, can redirect colonic tryptophan metabolism away from proteolytic (protein-fermenting) pathways and toward saccharolytic (sugar-fermenting) pathways.[10] In laboratory models using human faecal inocula, prebiotic supplementation reduced indole and skatole concentrations.[9] These findings suggest that increasing fibre relative to protein may reduce the bacterial populations that produce skatole, though the clinical effect has not yet been quantified in controlled human trials.
Hepatic clearance capacity
As described in the previous section, variation in cytochrome P450 enzyme activity affects how efficiently the liver clears skatole.[5] Beyond genetics, liver health matters. Any condition that impairs hepatic function, including fatty liver disease, chronic alcohol use, or hepatitis, may reduce skatole clearance and increase the amount entering systemic circulation. Age is also a factor: hepatic enzyme efficiency changes over time, which is one reason body odour can shift after 40.
Gut microbiome composition
The balance of bacterial species in the gut determines how much skatole is produced from a given amount of tryptophan. A gut dominated by proteolytic species, particularly Clostridium and Bacteroides, produces more skatole than one dominated by saccharolytic species such as Lactobacillus.[1][2]
Certain bacterial strains, particularly Lactobacillus species, can metabolise tryptophan through the indole-3-aldehyde pathway, which produces aryl hydrocarbon receptor (AhR) ligands rather than the malodorous skatole and indole.[6] When these strains are abundant in the gut, they compete for the same tryptophan substrate, effectively diverting it away from skatole production. Dietary fibre plays a role here as well: increased fibre availability redirects microbial tryptophan metabolism toward indole-3-propionic acid and other non-malodorous metabolites.[10]
In plain terms Why does this happen to some people and not others?
Three things work together: how much protein you eat (more protein means more raw material for skatole), which bacteria live in your gut (some produce skatole, others compete against them), and how well your liver processes it (some people's livers are genetically slower at clearing skatole). Two people eating the same diet can have very different skatole levels because of differences in their gut bacteria and liver enzymes.
5. Conditions linked to faecal body odour
Several medical conditions can increase skatole and indole production or impair their clearance, resulting in faecal body odour. Understanding these conditions helps distinguish between a dietary or microbial imbalance that can be managed and an underlying condition that requires medical attention.
Gut dysbiosis and small intestinal bacterial overgrowth (SIBO)
Gut dysbiosis, a shift in the microbial community toward a proteolytic, putrefactive profile, increases the production of skatole, indole, and other odorous metabolites.[2] In small intestinal bacterial overgrowth (SIBO), bacteria that normally reside in the colon colonise the small intestine, producing odorous metabolites higher in the digestive tract. The clinical association between SIBO and systemic symptoms is well established, though the specific contribution of SIBO to faecal body odour via elevated skatole has not been isolated in published studies.
Inflammatory bowel disease
Crohn's disease and ulcerative colitis alter tryptophan metabolism. Serum tryptophan levels are significantly reduced in patients with active IBD, and the kynurenine pathway is markedly activated, with elevated levels of downstream metabolites such as quinolinic acid correlating with disease activity.[11] This diversion of tryptophan toward the inflammatory kynurenine pathway reduces the amount available for microbial metabolism in the gut, altering the overall balance of tryptophan catabolites. The dysbiotic microbiome associated with active IBD may further shift the microbial community toward proteolytic species, though the specific effect on faecal skatole concentrations in IBD patients has not been quantified in published studies.
Liver dysfunction
Because the liver is the primary site of skatole clearance, any condition that impairs hepatic function can increase circulating skatole levels. This includes chronic liver disease, cirrhosis, and acute hepatic injury. The cytochrome P450 enzymes that metabolise skatole, including CYP1A2, CYP2E1, and CYP3A4, are known to be affected by liver disease and alcohol exposure.[5]
The TMAU differential: fishy versus faecal
Trimethylaminuria (TMAU) is sometimes considered when a person reports persistent body odour, but TMAU produces a characteristically fishy odour from trimethylamine (TMA), caused by mutations in the FMO3 gene that impair the conversion of TMA to its odourless oxide form.[12] A faecal body odour suggests skatole and indole from tryptophan metabolism, whereas a fishy body odour suggests TMA from choline and carnitine metabolism. For a full explanation of the ammonia and TMA pathway, read why your sweat smells like ammonia. The distinction matters because the dietary management, the diagnostic tests, and the underlying biochemistry are different for each condition.
Post-antibiotic disruption
Broad-spectrum antibiotics reduce overall gut microbial diversity and alter the community's metabolic output.[13] This disruption can shift the balance between saccharolytic and proteolytic species, though the specific effect on skatole production has not been quantified in clinical studies. Recovery of microbial diversity can take weeks to months after antibiotic cessation.
In plain terms Could my faecal body odour be caused by a medical condition?
Several conditions can cause or worsen faecal body odour. A gut bacterial imbalance (dysbiosis or SIBO) can increase skatole production. Inflammatory bowel disease diverts tryptophan away from normal gut metabolism, altering the balance of metabolites your body produces. Liver problems can reduce your body's ability to clear skatole from your blood. And antibiotics reduce gut microbial diversity, which can disrupt the balance between bacteria that produce skatole and those that suppress it. If the odour appeared suddenly, especially after illness, medication, or dietary change, a medical evaluation can identify whether an underlying condition is involved.
6. What can be done
Because faecal body odour from the skatole pathway involves production in the gut, transport through the blood, and expression at the skin surface, effective management requires addressing more than one point in the chain.
Dietary modification
Reducing the volume of unabsorbed tryptophan reaching the colon can lower skatole production. This does not require eliminating protein, but balancing protein intake with adequate fibre to promote saccharolytic over proteolytic fermentation. Increasing dietary fibre intake, particularly prebiotic fibres such as inulin-type fructans, can redirect microbial tryptophan metabolism away from skatole production.[10][9] A healthcare professional or registered dietitian can guide dietary adjustments that reduce skatole production without compromising nutritional adequacy.
Microbial rebalancing
Shifting the gut microbiome toward saccharolytic fermentation can reduce the bacterial populations responsible for skatole production. Lactobacillus species compete for tryptophan as a substrate but divert it through the indole-3-aldehyde pathway, producing beneficial aryl hydrocarbon receptor ligands rather than skatole.[6] Increased dietary fibre availability supports these saccharolytic populations and redirects tryptophan metabolism toward non-malodorous metabolites.[10] A healthcare professional or gastroenterologist can guide probiotic and prebiotic strategies tailored to individual gut profiles.
Topical management: why conventional deodorants fall short
Conventional deodorants and antiperspirants were designed to address body odour produced by bacteria on the skin surface breaking down sweat. They are effective against the volatile fatty acid and thioalcohol pathways (the sour and onion-like odours) because those pathways operate entirely on the skin. For a complete breakdown of how and why deodorants fail across all eleven odour pathways, read why your deodorant stops working. Faecal body odour from the skatole pathway operates through a different mechanism: the molecule arrives at the skin through the bloodstream, not through bacterial conversion of sweat precursors.
This means antimicrobial deodorants, which work by reducing the population of odour-producing skin bacteria, have limited effect on skatole-derived odour. The odour source is internal, and the skin bacteria are not producing it.
Products marketed as whole-body deodorants do not change this limitation. They are the same antimicrobial chemistry repositioned as a spot treatment for more areas of the body. Applying an antimicrobial product to the chest, back, and groin instead of just the armpits increases the coverage area, but the mechanism remains the same: it targets bacteria. If the odour is not being produced by bacteria on the skin surface, covering more skin with an antibacterial product does not address the source. The skatole pathway requires a fundamentally different mechanism, one that captures the molecule itself rather than targeting the bacteria that are not producing it.
Molecular trapping offers that approach. Certain compounds have cage-like molecular structures with internal cavities that can physically enclose small aromatic compounds, forming stable inclusion complexes that prevent the odorant from volatilising into the air. Selecting the right trapping compound for a given odorant depends on structural compatibility: the cavity must match the size and geometry of the target molecule. The VCS uses molecular trapping compounds selected specifically for their compatibility with skatole and indole. This is a fundamentally different mechanism from antimicrobial deodorants: instead of targeting bacteria, which are not producing the skatole in this pathway, the product captures the molecule itself at the skin surface.
There is another critical distinction. Because skatole reaches the skin through the bloodstream, it surfaces across the entire body, not only in the armpits. An underarm deodorant, even one with effective molecular trapping, covers a fraction of the skin area involved. Whole-body topical coverage is what this pathway demands. The BVI Lamellar Barrier Primer is a full-body daily lotion formulated with molecular trapping compounds that address skatole and indole across the entire skin surface. For people with skatole-pathway body odour, this is the relevant product, used in combination with the Bio-Clear: Poly Acid Daily Wash and, where needed, the BVI Endurance Concentrate for additional protection in targeted zones. For a full explanation of what each product does and how they work together, read the Volatile Control System introduction.
In plain terms Why doesn't regular deodorant help with this kind of body odour?
Regular deodorants fight bacteria on your skin that produce sour or onion-like smells from sweat. Faecal body odour is different because the smelly molecule, skatole, arrives at your skin from inside your body through your bloodstream. Killing skin bacteria does not stop it. A topical product designed for this problem needs to physically trap the skatole molecule as it reaches the skin surface, preventing it from reaching the air. The VCS uses molecular trapping compounds that do exactly this. And because skatole reaches your skin everywhere through your bloodstream, not just your armpits, this requires a whole-body product. The BVI Lamellar Barrier Primer is a full-body daily lotion designed for exactly this purpose.
When to see a doctor
Persistent faecal body odour warrants medical evaluation, particularly if it appeared suddenly, worsened after illness, antibiotic use, or hormonal transition (read perimenopause and body odour if that applies), or is accompanied by digestive symptoms such as bloating, abdominal pain, diarrhoea, or changes in stool consistency. These patterns may suggest gut dysbiosis, SIBO, inflammatory bowel disease, malabsorption, or impaired liver function.
A gastroenterologist can investigate with stool analysis (including microbial profiling), breath tests for SIBO, blood tests for liver and kidney function, and, where clinically indicated, imaging of the gastrointestinal tract. The objective is to identify whether an underlying condition is driving elevated skatole production or impairing its clearance.
A doctor addresses the underlying condition. The Volatile Control System addresses whatever component of the odour is manageable at the skin surface. If the VCS cannot fully resolve the odour, no other topical product will. What remains belongs to medicine.
The skatole pathway described in this article is one of 11 distinct biochemical odour pathways the VCS was formulated to address. Most deodorants were built for the volatile fatty acid and thioalcohol pathways that operate on the skin surface. They were never designed for molecules that arrive through the bloodstream.
For the skatole pathway specifically, the VCS takes a system approach. The Bio-Clear: Poly Acid Daily Wash cleanses the skin surface and establishes the acid mantle foundation. The BVI Lamellar Barrier Primer, a full-body daily lotion, provides molecular trapping compounds that capture skatole and indole across the entire skin surface throughout the day. The BVI Endurance Concentrate adds concentrated protection in targeted zones where apocrine gland density is highest. Together, these products address both the systemic component of skatole-pathway odour through whole-body coverage via the Primer and the localised component through concentrated zones via the BVI Endurance Concentrate. This is combined with the VCS's broader mechanism set: selective antimicrobial action, biofilm disruption, pH management, and skin barrier support.
For people whose faecal body odour has a skin-surface component, the VCS manages it. For people whose faecal body odour is primarily systemic, the VCS provides topical relief while the underlying gut or liver source is addressed medically. If the VCS cannot fully resolve the odour, no other topical product will. What remains belongs to medicine.
Read the full Volatile Control System introduction for a breakdown of each product and its role in the system.
Scientific references
- Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9(1):3294. doi:10.1038/s41467-018-05470-4
- Liu D, Wen B, Zhu K, et al. New insights into gut-bacteria-derived indole and its derivatives in intestinal and liver diseases. Front Pharmacol. 2021;12:769501. doi:10.3389/fphar.2021.769501
- Whitehead TR, Price NP, Drake HL, Cotta MA. Catabolic pathway for the production of skatole and indoleacetic acid by the acetogen Clostridium drakei, Clostridium scatologenes, and swine manure. Appl Environ Microbiol. 2008;74(6):1950-1953. doi:10.1128/AEM.02458-07
- Badawy AAB. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res. 2017;10:1178646917691938. doi:10.1177/1178646917691938
- Yan Z, Easterwood LM, Maher N, et al. Metabolism and bioactivation of 3-methylindole by human liver microsomes. Chem Res Toxicol. 2007;20(1):140-148. doi:10.1021/tx060239e
- Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716-724. doi:10.1016/j.chom.2018.05.003
- Xu B, Qiu W, Gao X, et al. Advances in microbial degradation of skatole: a review. Curr Res Microb Sci. 2025;8:100378. doi:10.1016/j.crmicr.2025.100378
- Huang Z, Boekhorst J, Fogliano V, Knol J, Killiaan AJ. Impact of high-fiber or high-protein diet on the capacity of human gut microbiota to produce tryptophan catabolites. J Agric Food Chem. 2023;71(8):3640-3649. doi:10.1021/acs.jafc.2c08953
- Wang X, Gibson GR, Costabile A, et al. Prebiotic supplementation of in vitro fecal fermentations inhibits proteolysis by gut bacteria and reduces production of indole and phenol. Appl Environ Microbiol. 2019;85(3):e02749-18. doi:10.1128/AEM.02749-18
- Sinha AK, Laursen MF, Brinck JE, et al. Dietary fibre directs microbial tryptophan metabolism towards serotonin and indole-3-propionic acid. Nat Microbiol. 2024;9(7):1810-1821. doi:10.1038/s41564-024-01737-3
- Nikolaus S, Schulte B, Al-Massad N, et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology. 2017;153(6):1504-1516. doi:10.1053/j.gastro.2017.08.028
- Treacy EP, Akerman BR, Chow LM, et al. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet. 1998;7(5):839-845. doi:10.1093/hmg/7.5.839
- Ramirez J, Guarner F, Bustos Fernandez L, et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020;10:572912. doi:10.3389/fcimb.2020.572912